Bioimpedance Analysis in CKD and HF Patients: A Critical Review of Benefits, Limitations, and Future Directions
Edoardo La Porta1,2, Alessandro Faragli3,4,5,6, Alexander Herrmann3,4,7
1UOC Nephrology, Dialysis and Trasplantation, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy.
Journal of Clinical Medicine
|November 9, 2024
Abstract:
Bioimpedance analysis (BIA) is a validated non-invasive technique already proven to be useful for the diagnosis, prognosis, and management of body fluids in subjects with heart failure (HF) and chronic kidney disease (CKD). Although BIA has been widely employed for research purposes, its clinical application is still not fully widespread. The aim of this review is to provide a comprehensive overview of the state of the art of BIA utilization by analyzing the clinical benefits, limitations, and potential future developments in this clinically unexplored field.


